// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Impact of different classification criteria on the prevalence of radiographic foot osteoarthritis: data from the Chingford 1000 women study

J.B. Arnold - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Chronic pain treatment satisfaction in musculoskeletal disease: differences between osteoarthritis and chronic low back pain in medication switching, opioid use, and utilization of non-pharmacologic treatments

J. Mali - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Chronic low back pain

Epimorph

One in seven cases of incident knee osteoarthritis is accelerated knee osteoarthritis: data from the Chingford cohort

J.B. Driban - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Association of glucose homeostasis measures and metabolic syndrome with knee cartilage defects and cartilage volume in young adults

T. Meng - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

N/A

Association of body composition, physical activity and physical performance with knee cartilage thickness and subchondral bone area in young adults

T. Meng - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prospective association of physical activity to follow-up fatigue in knee osteoarthritis: the most study

H.O. Fawole - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Knee osteoarthritis

N/A

Incidence and progression of first METATARS0-phalangeal joint osteoarthritis over a 19-year period in the Chingford 1000 women cohort

L. Gates - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

What is the risk of knee osteoarthritis after a history of knee injury in young adults? A population-based cohort study

B. Snoeker - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Knee osteoarthritis

N/A

Gene expression and DNA methylation analysis at the OA susceptibility locus marked by rs6516886 prioritizes specific gene and regulatory sequences as functional targets of the association signal

E. Parker - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implementation priorities for osteoarthritis management programs

J.P. Eyles - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Mid-term follow up and analysis of the subsequent need for hip replacement following completion of the chain (cycling against hip pain) programme

T.W. Wainwright - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in bone shape are both a risk factor for and a result of hip osteoarthritis, a follow-up study in the check cohort

W. Gielis - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Diffuse tibiofemoral cartilage change prior to the development of accelerated knee osteoarthritis: data from the osteoarthritis initiative

M. Harkey - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Intersite comparison and test-retest reliability of cartilage thickness and compostional analysis in the approach study – a 2-year multicenter European exploratory study for phenotype characterizaton of knee osteoarthritis

F. Eckstein - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Novel composite knee structure metrics of disease activity and cumulative damage predict the development of accelerated knee osteoarthritis: data from the osteoarthritis initiative

M. Harkey - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

3D joint space mapping is a better predictor of future total hip replacement than current 2D radiographic gold standards: an ages-reykjavik study

T.D. Turmezei - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

The effects of weight loss on imaging outcomes in overweight or obese people with osteoarthritis in the hip or knee joint: a systematic review of imaging reporting in interventional studies

C.L. Daugaard - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

3D joint space mapping of the knee: a feasibility study with standing CT data from the multicenter osteoarthritis study

S.B. Low - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Bone marrow lesion subtype and symptoms in knee osteoarthritis

T. Perry - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

Ergocalciferol

Association of hip shapes with knee osteoarthritis outcomes in older-adults

I.P. Munugoda - Osteoarthritis Research Society International (OARSI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Copyright © 2026. QuantiNova All rights reserved